Research Overview Understanding the Triple-Receptor Mechanism Retatrutide is the first clinically advanced peptide engineered for balanced agonism at three class B G protein-coupled receptors simultaneously: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
van der Pol A, van Gilst WH, Voors AA, van der Meer P
Caffeine on an empty stomachcommon for people whose appetite drops dramaticallycan trigger nausea and stomach irritation
With copay assistance provided by this program, the cost of the drug for eligible participants may be as low as $25 for a 1- or 3-month supply
Frequently Asked Questions Have GLP-1 Patches Earned FDA Approval
Dainichi T, Kitoh A, Otsuka A, Nakajima S, Nomura T, Kaplan DH, Kabashima K